Olsztynski Osrodek Onkologiczny Kopernik Sp. z o.o.
- Address
- lock Available on a paid plan
Neoplasms
At Olsztynski Osrodek Onkologiczny Kopernik Sp. z o.o., clinical research in oncology focuses on cancer care, with studies centered on improving treatment options for people affected by solid tumors and early-stage disease.
- Breast cancer research exploring whether adding a new therapy can improve outcomes after surgery for patients with high-risk, hormone receptor-positive, HER2-negative disease.
- Advanced solid tumors studies evaluating a novel immunotherapy approach to better understand treatment effectiveness in patients with difficult-to-treat cancers.
This work at the Chemotherapy Clinic reflects a clear emphasis on testing new cancer treatments and expanding options for patients with neoplastic diseases.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Olsztynski Osrodek Onkologiczny Kopernik Sp. z o.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 1 Dose Escalation and Cohort Expansion Study of Anti-PD-1 Monoclonal Antibody TSR-042 in Advanced Solid Tumors | Tesaro Inc. | Phase I | Not Recruiting | Apr 2017 | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.